Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9876
PUT
POSCO
PKX
$17.7B
| $276K | ﹤0.01% |
6,200
-7,600
| -55% | -$419K |
|
9877
Tenaya Therapeutics
TNYA
$163M
| $276K | ﹤0.01% |
+48,960
| New | +$396K |
|
9878
CALL
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.7M
| $276K | ﹤0.01% |
+24,100
| New | +$277K |
|
9879
CALL
Voyager Therapeutics
VYGR
$201M
| $276K | ﹤0.01% |
46,700
-46,000
| -50% | -$311K |
|
9880
PUT
Zumiez
ZUMZ
$314M
| $276K | ﹤0.01% |
10,600
-1,800
| -15% | -$60.6K |
|
|
ALBO
9881
PUT
DELISTED
Albireo Pharma Inc
ALBO
| $276K | ﹤0.01% |
13,900
+7,000
| +101% | +$185K |
|
9882
PUT
Dole
DOLE
$1.26B
| $275K | ﹤0.01% |
32,500
-56,900
| -64% | -$625K |
|
9883
Fulcrum Therapeutics
FULC
$285M
| $275K | ﹤0.01% |
56,047
-56,156
| -50% | -$549K |
|
9884
CALL
Hydrofarm Holdings
HYFM
$7M
| $275K | ﹤0.01% |
7,910
+1,150
| +17% | +$93.6K |
|
9885
PUT
NWPX Infrastructure Inc
NWPX
$1.12B
| $275K | ﹤0.01% |
+9,200
| New | +$273K |
|
9886
Root
ROOT
$797M
| $275K | ﹤0.01% |
12,852
+162
| +1% | +$4.39K |
|
9887
CALL
SK Telecom
SKM
$14.8B
| $275K | ﹤0.01% |
12,300
+2,280
| +23% | +$57.5K |
|
9888
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
| $275K | ﹤0.01% |
11,088
-3,561
| -24% | -$90.3K |
|
|
NATI
9889
PUT
DELISTED
National Instruments Corp
NATI
| $275K | ﹤0.01% |
+8,800
| New | +$312K |
|
|
IUSA
9890
DELISTED
Amberwave Invest USA JSG Fund
IUSA
| $275K | ﹤0.01% |
18,019
+6,342
| +54% | +$104K |
|
|
ARGUW
9891
DELISTED
Argus Capital Corp. Warrant
ARGUW
| $275K | ﹤0.01% |
1,374,288
+11,788
| +0.9% | +$3.49K |
|
9892
Avista
AVA
$3.28B
| $274K | ﹤0.01% |
6,294
-16,532
| -72% | -$711K |
|
9893
Encompass Health
EHC
$12.2B
| $274K | ﹤0.01% |
6,130
-86,507
| -93% | -$4.44M |
|
9894
PUT
iShares Global Energy ETF
IXC
$2.77B
| $274K | ﹤0.01% |
8,100
+2,200
| +37% | +$82.4K |
|
9895
PUT
Marcus & Millichap
MMI
$1.2B
| $274K | ﹤0.01% |
+7,400
| New | +$322K |
|
|
HYZN
9896
CALL
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $274K | ﹤0.01% |
1,866
-3,474
| -65% | -$736K |
|
|
IPOF
9897
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $274K | ﹤0.01% |
27,600
-88,700
| -76% | -$899K |
|
9898
CALL
Sphere 3D
ANY
$18.1M
| $273K | ﹤0.01% |
7,266
-2,340
| -24% | -$202K |
|
|
BRT
9899
PUT
BRT Apartments
BRT
$270M
| $273K | ﹤0.01% |
+12,700
| New | +$280K |
|
9900
PUT
Americold
COLD
$4.25B
| $273K | ﹤0.01% |
9,100
-3,500
| -28% | -$97.3K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.